LAVA Therapeutics N.V. (LVTX)
USD 1.01
(-2.88%)
USD 1.01
(-2.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 6.76 Million | 19.39 Million | 5.35 Million | 3.74 Million | - |
| Cost of Revenue | 3.48 Million | - | - | 15.7 Million | 8.34 Million |
| Gross Profit | 3.28 Million | 19.39 Million | 5.35 Million | -11.95 Million | -8.34 Million |
| Operating Expenses | 46.54 Million | 51.3 Million | 46.92 Million | 3.58 Million | 1.25 Million |
| Selling, General and Administrative Expenses | 12.72 Million | 14.12 Million | 12.01 Million | 2.71 Million | 1.23 Million |
| Research and Development Expenses | 33.81 Million | 40.1 Million | 36.94 Million | 15.7 Million | 8.34 Million |
| Other Expenses | - | - | - | - | - |
| Cost and Expenses | 50.02 Million | 51.3 Million | 46.92 Million | 19.28 Million | 9.6 Million |
| Operating Income | -43.25 Million | -34.83 Million | -43.61 Million | -14.67 Million | -9.58 Million |
| Interest Expense | - | - | 625 Thousand | 342 Thousand | - |
| Income Tax Expense | 279 Thousand | 249 Thousand | 157 Thousand | 43 Thousand | - |
| Earnings before Tax | -41.69 Million | -31.65 Million | -42.19 Million | -15.88 Million | -9.68 Million |
| Net Income | -41.97 Million | -31.9 Million | -42.35 Million | -15.92 Million | -9.68 Million |
| Earnings Per Share Basic | -1.57 | -1.23 | -2.14 | -39.90 | -21.65 |
| Earnings Per Share Diluted | -1.57 | -1.23 | -2.14 | -39.90 | -21.65 |
| Weighted Average Shares Outstanding | 26.73 Million | 25.92 Million | 19.75 Million | 25.35 Million | 18.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.73 Million | 25.92 Million | 19.75 Million | 25.35 Million | 18.41 Million |
| Gross Margin | 0.49 | 1.00 | 1.00 | -3.19 | - |
| EBIT Margin | -5.97 | -1.77 | -8.09 | -3.86 | - |
| Profit Margin | -6.20 | -1.65 | -7.92 | -4.25 | - |
| EBITDA | -40.41 Million | -30.87 Million | -41.01 Million | -14.65 Million | -9.48 Million |
| Earnings Before Tax Margin | -6.39 | -1.80 | -8.15 | -3.92 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 6.99 Million | 353 Thousand | 6.76 Million | 53 Thousand | 5.13 Million |
| Cost of Revenue | 228 Thousand | - | 154 Thousand | 3.48 Million | 10 Thousand | 2.38 Million |
| Gross Profit | -228 Thousand | 6.99 Million | 199 Thousand | 3.28 Million | 43 Thousand | 2.75 Million |
| Operating Expenses | 9.02 Million | 8.28 Million | 7.48 Million | 47.95 Million | 9.63 Million | 16.05 Million |
| Selling, General and Administrative Expenses | 3.02 Million | 2.93 Million | 2.28 Million | - | 2.85 Million | 3.69 Million |
| Research and Development Expenses | 6.33 Million | 6 Million | 3.36 Million | - | 7.91 Million | 12.59 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 9.02 Million | 8.28 Million | 7.63 Million | 51.43 Million | 9.64 Million | 18.44 Million |
| Operating Income | -9.36 Million | -1.95 Million | -5.44 Million | -43.25 Million | -10.72 Million | -13.54 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 85 Thousand | 69 Thousand | 61 Thousand | 279 Thousand | 50 Thousand | 97 Thousand |
| Earnings before Tax | -8.21 Million | -484 Thousand | -6.43 Million | -41.69 Million | -8.78 Million | -12.6 Million |
| Net Income | -8.29 Million | -553 Thousand | -6.49 Million | -41.97 Million | -8.83 Million | -12.7 Million |
| Earnings Per Share Basic | -0.31 | -0.02 | -0.24 | - | -0.34 | -0.48 |
| Earnings Per Share Diluted | -0.31 | -0.02 | -0.24 | - | -0.34 | -0.48 |
| Weighted Average Shares Outstanding | 26.82 Million | 26.79 Million | 26.76 Million | 26.73 Million | 26.28 Million | 26.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.82 Million | 26.79 Million | 26.76 Million | 26.73 Million | 26.28 Million | 26.28 Million |
| Gross Margin | - | 1.00 | 0.56 | 0.49 | 0.81 | 0.54 |
| EBIT Margin | - | -0.26 | -14.90 | - | -199.53 | -2.61 |
| Profit Margin | - | -0.08 | -18.41 | -6.20 | -166.72 | -2.47 |
| EBITDA | -9.24 Million | -1.8 Million | -5.25 Million | - | -10.57 Million | -13.39 Million |
| Earnings Before Tax Margin | - | -0.28 | -15.42 | -6.39 | -202.40 | -2.64 |
NVTQF
NWH
605588
BUX
CYCN
4166